AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Algorae Pharmaceutical Option Expiring 19-APR-2024

0.001

0.000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:0.001

Open:0.001

Low:0.001

Close:0.001

52wk High:0.001

52wk Low:0.001

Shares:- -

Float Shares:- -

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Algorae Pharmaceutical Option Expiring 19-APR-2024

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.lctglobal.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/1AIOA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AIOA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AIOA.AU\",,,,,undefined,":{"symbol":"1AIOA.AU","market":"AU","secType":"STK","nameCN":"Algorae Pharmaceutical Option Expiring 19-APR-2024","latestPrice":0.001,"timestamp":1771818044553,"preClose":0.001,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"Algorae Pharmaceutical Option Expiring 19-APR-2024","floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"02-23 14:40:44 AEDT","open":0.001,"high":0.001,"low":0.001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771822800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.001,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AIOA.AU\",,,,,undefined,":{"symbol":"1AIOA.AU","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.001,"amplitude":0,"preClose":0.001,"low":0.001,"week52Low":0.001,"pbRate":"--","week52High":0.001,"institutionHeld":0,"latestPrice":0.001,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.001,"prevYearClose":0.001,"prevWeekClose":0.001,"prevMonthClose":0.001,"prevQuarterClose":0.001,"fiveDayClose":0.001,"twentyDayClose":0.001,"sixtyDayClose":0.001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AIOA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AIOA.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.lctglobal.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.0666},{"period":"6month","weight":0.055},{"period":"1year","weight":0.2181},{"period":"ytd","weight":0.0215}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.","exchange":"ASX","name":"Algorae Pharmaceutical Option Expiring 19-APR-2024","nameEN":"Algorae Pharmaceutical Option Expiring 19-APR-2024"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"1AIOA.AU\",market:\"AU\",,,undefined,":null}}